Zobrazeno 1 - 10
of 20
pro vyhledávání: '"J. C. García-Ruiz"'
Autor:
Guillermo Deben, María José Ramírez, A. Martín García-Sancho, Jimena Cannata-Ortiz, Juan-Manuel Sancho, E. González Barca, Maria Vidal, Ana Jiménez-Ubieto, Norma C. Gutiérrez, Santiago Mercadal, Ana García-Noblejas, J. C. García-Ruiz, Carmen Albo, Ana Africa Martín López, Reyes Arranz, Eulogio Conde, Silvana Novelli, P. Ríos Rull, S. González de Villambrosía, Concepción Nicolás, Rafael Rojas, Armando López-Guillermo
Publikováno v:
Annals of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Guidelines recommend autologous stem cell transplantation (ASCT) consolidation in first complete or partial response after regimens including rituximab (R) and high-dose AraC (HDAC), but its use beyond that response is questioned. We present a retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f82cc1d9b30445ed05c3e4331399ec
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7416
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7416
Autor:
Carmen Albo, Juan José Lahuerta, Fernando Solano, Andrés Insunza, Carlos Grande, Javier de la Serna, Angel Leon, Santiago Larregla, J. Bargay, Rosa Toscano, Jesús F. San Miguel, Maria Ortiz, Luis Garcia-Alonso, Jose D. Gonzalez-San Miguel, J. C. García-Ruiz, Eulogio Conde, Pilar Vivancos, Joaquin Martinez-Lopez, Rafael Cabrera
Publikováno v:
British Journal of Haematology. 120:296-303
Between 1994 and 1999, 88 multiple myeloma (MM) patients were included in a phase II study to evaluate a tandem autologous stem cell transplantation (ASCT) programme. The first was conditioned with melphalan 200 mg/m2 (MEL200-ASCT1), and the second w
Autor:
Garcia Lj, Perez-Lopez C, J. C. García-Ruiz, de la Serna J, de la Rubia J, J. Bargay, Joaquin Martinez-Lopez, Carlos Solano, Luis Palomera, Eulogio Conde, San Mj, Rafael Cabrera, J. J. Lahuerta, Anna Sureda, J. Bladé, F. Hernández, Carlos Grande, Dolores Caballero, Adela Escudero, A. Leon, J. Marin, Adrian Alegre, Pilar Giraldo, Pérez-Equiza K
Publikováno v:
Leukemia & Lymphoma. 43:67-75
After a previous analysis that did not detect clear differences in the results of three conditioning regimens used for autologous stem cell transplantation (ASCT) in patients from the Spanish Registry for Transplant in Multiple Myeloma (MM), we have
Autor:
Angel Leon, Jesús F. San-Miguel, Alfonso Morales, Javier de la Serna, José García-Laraña, Adrian Alegre, Juan Besalduch, Carlos Grande, Javier de la Rubia, Ana Sureda, José M. Moraleda, Joaquin Martinez-Lopez, Katy Perez-Equiza, Lourdes Vázquez, Eulogio Conde, Juan José Lahuerta, Jose D. Gonzalez-San Miguel, Rafael Martínez, Joan Bladé, Joaquín Díaz-Mediavilla, J. C. García-Ruiz, Rafael Cabrera
Publikováno v:
British Journal of Haematology. 109:438-446
We have retrospectively analysed 344 multiple myeloma (MM) patients (202 de novo patients) treated in a non-uniform way in whom high-dose therapy and autologous stem cell transplantation (ASCT) response was simultaneously measured by both electrophor
Autor:
Eulogio Conde, J P Torres, D Caballero, José Rifón, José Luis Díez-Martín, E Prieto, J.J. Lahuerta, Maria Vidal, J M De Pablos, Rafael Barroso Cabrera, Ramón García-Sanz, Miguel-Teodoro Hernández, Carlos Solano, P. Torres, Luis Palomera, J Constela, J Olanguren, A Alegre, A. Leon, R. Martínez, G Acebede, MJ Peñarrubia, Joaquín Díaz-Mediavilla, Juan Besalduch, J de la Rubia, Jaime Merino Sánchez, E Pérez-Esquiza, A Escudero, J. C. García-Ruiz, Anna Sureda, Rodolfo Mataix, J F San Miguel, Ricardo Parody, J L Bello, Ana Rivas, José M. Moraleda, José D. González, Fernando Hernández, José A. Pérez-Simón, José García-Laraña, J. Bladé, Juan Maldonado, Dolores Carrera
Publikováno v:
ResearcherID
Introduction: Renal function is one of the most important prognostic factors in multiple myeloma (MM). Patients with renal failure are generally excluded from high dose therapy even though they display a poor prognosis with conventional chemotherapy
Autor:
Joan Besalduch, J. C. García-Ruiz, Javier de la Rubia, Ramón García-Sanz, Jesús F. San Miguel, Consuelo Rayon, Adrian Alegre, Laura Rosiñol, Joan Bladé, Santiago Gardella, Albert Oriol, Isabel Navarro, Joaquín Díaz-Mediavilla, Juan José Lahuerta, Miquel Granell, Javier Lopez Jimenez, Belén Hernández-Ruiz, Miguel T. Hernández-García
Publikováno v:
HAEMATOLOGICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Several studies of autologous stem cell transplantation in primary refractory myeloma have produced encouraging results. However, the outcome of primary refractory patients with stable disease has not been analyzed separately from the outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4430bb9c1a7c9afe0f1f8546ec6c1cee
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11415
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11415
Autor:
R M, Izu-Belloso, J C, García-Ruiz
Publikováno v:
Actas dermo-sifiliograficas. 103(8)
Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoid tumors that originate primarily in the skin. Most PCLs (75%) are T-cell lymphomas and only 20% to 25% involve B cells. It is important to differentiate between cutaneous lymphom
Autor:
Maria Cruz Viguria, Maria Carmen Gomez del Castillo, Rafael Cabrera, Carlos Grande, Jesús F. San Miguel, José Luis Guzman-Zamudio, Maria-Victoria Mateos, Rafael Martínez, Felipe de Arriba, José M. Moraleda, Joaquin Martinez-Lopez, José García-Laraña, Adrian Alegre, Juan José Lahuerta, Joan Besalduch, Javier de la Rubia, Jose D. Gonzalez-San Miguel, Eulogio Conde, Joan Bladé, J. C. García-Ruiz, Anna Sureda
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
GEM (Grupo Español de MM) and PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatía Maligna) Cooperative Study Groups.-- et al.
For establishing the true effect of different response categories in patients with multiple myeloma (MM
For establishing the true effect of different response categories in patients with multiple myeloma (MM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04297b0217bb7b0d918911dcde33d56
http://hdl.handle.net/10261/61107
http://hdl.handle.net/10261/61107
Publikováno v:
Actas dermo-sifiliograficas. 99(7)
We describe the case of a 17-year-old patient with rapidly progressing and aggressive mycosis fungoides, with multiple cutaneous tumors and large cell transformation. She was initially treated with 3 cycles of high-dose chemotherapy with mega-CHOP (c
Autor:
J C, García-Ruiz, E, Amutio, I, Hernández, C, Alvarez, F, Floristán, I, Zuazúa, A, Alvarez-Blanco, J, Pontón
Publikováno v:
Revista iberoamericana de micologia. 15(3)
Scedosporium prolificans is a filamentous fungus which has been recently identified as the aetiologic agent of severe infections in patients with haematological malignancies. Due to the resistance of S. prolificans to all known antifungals there are